Azidus Brasil: all 80 studies

Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and InfluenzaNot yet recruitingNCT06817096Phase 3
• Safety of UFRJvac, Trivalent COVID-19 VaccineNot yet recruitingNCT06303635
• IVIG Boya: Safety, Efficacy, and PharmacokineticsNot yet recruitingNCT06150833Phase 3
• Efficacy and Safety of NestaCell® in Huntington's DiseaseNot yet recruitingNCT06097780Phase 3
• Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIGNot yet recruitingNCT06089122Phase 3
• Dose-response Evaluation of the Cellavita HD Product in Patients With Huntington's DiseaseCompletedNCT03252535Phase 2Results posted
• Efficacy And Safety Of Probiatop In The Treatment Of Digestive SymptomsCompletedNCT05603403Phase 4
• Safety and Immunogenicity of the RNA MCTI CIMATEC HDT VaccineStatus unknownNCT05542693Phase 2
• Study To Evaluate The Sensitivity Of The Linda Thermal DeviceStatus unknownNCT05009277
• Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 PatientsWithdrawnNCT04441398Phase 2/3
• Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19WithdrawnNCT04435314Phase 2
• Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19Status unknownNCT04423861Phase 3
• Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 PatientsStatus unknownNCT04352465Phase 1/2
• Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19SuspendedNCT04348474Early Phase 1
• Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19CompletedNCT04348409Not applicable
• Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19SuspendedNCT04329572Early Phase 1
• NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 PneumoniaCompletedNCT04315987Phase 2
• Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington's Patients.Status unknownNCT04219241Phase 2/3
• Pharmacokinetics and Pharmacodynamics Assessment of Drug Eritromax Compared to Eprex in Healthy Subjects.CompletedNCT03572647Phase 1
• Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's DiseaseStatus unknownNCT02728115Phase 1
• Clinical Efficacy of Two Erythropoietin Drug in Participants With Secondary Anemia to Chronic Kidney Disease.TerminatedNCT01695759Phase 3
• Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + HydrochlorothiazideCompletedNCT01692717Phase 1
• Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous AdministrationCompletedNCT01692171Phase 1
• Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single DoseCompletedNCT01692158Phase 1
• PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Human RecombinantCompletedNCT01685359Phase 1
• PK and PD Crossover Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects.CompletedNCT01685333Phase 1
• Clinical Efficacy of Postpartum Immunization of Rh and Coombs Negative Women With Sensitization Risk.SuspendedNCT01666249Phase 3
• PK and PD Parallel Study After Multiple Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy Subjects.Status unknownNCT01664221Phase 1
• PK and PD Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Eritromax and Eprex, in Healthy SubjectsStatus unknownNCT01664195Phase 1
• PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (SUBCUTANEOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALSStatus unknownNCT01652638Phase 1
• PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (INTRAVENOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALSStatus unknownNCT01651923Phase 1
• Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G-CSF)Produced by Blausiegel Indústria e Comércio Ltda. Compared to Granulokine Produced by Produtos Roche Químicos e Farmacêuticos S/A.CompletedNCT01549301Phase 1
• Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Somatropin Produced by Laboratory Blausiegel Indústria e Comércio Ltda., Compared to Saizen® From Laboratory Merck Serono S.A.Status unknownNCT01494779Phase 1
• Evaluation of Ciclo 21® Effect (Levonorgestrel + Ethinyl Estradiol) Compared to Nordette®.CompletedNCT01480778Phase 3
• Study With Chondroitin Sulfate and Glucosamine Sulfate (in Dosage Capsule and Sachet) in Treating OsteoarthritisStatus unknownNCT01293305Phase 3
• Efficacy and Comparative of the Association Beclomethasone Clotrimzaol + Gentamicin in Patients With Acne ContaminatedSuspendedNCT01244256Phase 2/3
• Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic DermatitisStatus unknownNCT01239719Phase 3
• Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With PsoriasisCompletedNCT01229085Phase 3
• Safe Use of Heparin Sodium in Patients With Chronic Renal Failure.SuspendedNCT01229072Phase 2/3
• Effectiveness of Association Mometasone Furoate 0.1% and Salicylic Acid 5% Compared With Mometasone FuroateSuspendedNCT01228656Phase 2
• Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two DrugsWithdrawnNCT01228643Phase 3
• Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis.CompletedNCT01228630Phase 3
• Pharmacokinetics and Pharmacodynamics of Interferon Alpha 2ACompletedNCT01228422
• Study for Effectiveness Evaluation of Panax Ginseng, Vitamins and Minerals (Natugerin®) in Improvement of Stress and FatigueStatus unknownNCT01228006Phase 3
• Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial ConjunctivitisStatus unknownNCT01227915Phase 3
• Clinical Efficacy of the Drug Ster® Compared With Predfort® in Control of Postoperative Inflammation in Cataract SurgeryCompletedNCT01227876Phase 3
• Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial ConjunctivitisStatus unknownNCT01227863Phase 3
• Efficacy and Safety of a New Botulinum Toxin Type A for Treatment of Facial Expression LinesCompletedNCT01180348Phase 3
• Efficacy and Safety of the Association Drugs in Patients With Allergic DermatitisWithdrawnNCT01125761Phase 3
• Comparative Efficacy of the Suppository Versus Guaiacol Suppository Versus Guaifenesin Syrup in Pediatric Patients With Cough Due the Infectious OriginStatus unknownNCT01119534Phase 3
• Comparative Efficacy of Two Preparations of the Association Diosmin (450 mg) + Hesperidin (50 mg) in the Treatment of Chronic Venous Insufficiency (CVI)Status unknownNCT01110512Phase 3
• Efficacy and Safety of the Herbal Medicine Sominex ® (Passiflora Incarnata L., Valeriana Officinalis L. and Crataegus Oxyacantha L.), Manufactured by the Laboratory EMS S / A in Patients With Psychophysiological InsomniaStatus unknownNCT01100645Phase 3
• Effectiveness Evaluation of Panax Ginseng, Vitamins and Minerals in Improvement of Stress and FatigueSuspendedNCT01100632Phase 3
• Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg Compared To Product Sandostatin LAR ®SuspendedNCT01086982Phase 1
• Pharmacokinetics and Pharmacodynamics of the Interferon Beta-1a Produced by Laboratorio Quimico Farmaceutico Bergamo Compared to Interferon Beta-1a (Rebif - Merck Serono) in Healthy SubjectsCompletedNCT01074593Phase 1
• Efficacy And Safety Of Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary BypassStatus unknownNCT01072955Phase 3
• Efficacy And Safety Of Unfractionated Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary BypassStatus unknownNCT01072747Phase 3
• Pharmacodynamics of Lorelin Depot (Leuprorelin Acetate - Bergamo) Compared to Lupron Depot ® (Leuprorelin Acetate - Abbot)CompletedNCT01071005Phase 1
• Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic RhinitisWithdrawnNCT01055756Phase 3
• Pharmacodynamics Aspects Of Porcine Heparin Sodium, Produced by Eurofarma, Compared Heparin Sodium, Produced by APP Pharmaceuticasls, in Patients With Chronic Renal FailureStatus unknownNCT01034488Phase 2/3
• Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic InsufficiencyStatus unknownNCT01012908Phase 2/3
• Efficacy and Safety Clinical Trial of the Combination of Acetylsalicylic Acid, Sodium Bicarbonate and Citric Acid, Produced by Geolab Pharmaceutical Industries Ltd., Compared to Acetylsalicylic Acid (Aspirin ® - Bayer) in Patients With Episodic Tension-type Headache.Status unknownNCT01012349Phase 2/3
• Efficacy of Sodium Heparin for Prophylaxis of Venous Thromboembolism in Surgical PatientsStatus unknownNCT00934167Phase 2/3
• Comparison of Two Heparin Formulations in Patients With Chronic Renal Failure.Status unknownNCT00914472Phase 3
• Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical PatientsWithdrawnNCT00912483Phase 3
• Efficacy and Safety of Sodium Heparin in Patients Submitted to Heart Surgery Using BypassStatus unknownNCT00905216Phase 3
• Efficacy and Safety of Sodium Heparin in Patients (Cristália)CompletedNCT00894998Phase 3
• Efficacy and Safety of Sodium HeparinCompletedNCT00894985Phase 3
• Efficacy and Safety of Sodium Heparin in PatientsCompletedNCT00894959Phase 3
• Efficacy and Safety of Sodium Heparin (Eurofarma)CompletedNCT00894829Phase 3
• Efficacy and Safety of Sodium Heparin (Hipolabor) in PatientsCompletedNCT00894673Phase 3
• Effectiveness of Glucosamine + Chondroitin in OsteoarthrosisCompletedNCT00860873Phase 3
• Effectiveness and Safety of the of Guaifenesin, Doxylamine Succinate and Hydrochloride Etafedrine Syrup in Improvement of Symptoms Resulting From Acute Respiratory Infections.Status unknownNCT00857987Phase 3
• Efficacy of the Combination Bismuth + Neomycin + Procaine in the Treatment of Recurrent Aphthous UlcerationCompletedNCT00857688Phase 3
• Pharmacodynamics and Non-Clinical Inferiority of Heparin Sodium (Cristália) Compared With the Product Liquemine (Roche) in Chronic Renal FailureCompletedNCT00828776Phase 2/3
• Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In Treatment Of MelasmaSuspendedNCT00717652Phase 2/3
• Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With PsoriasisCompletedNCT00715975Phase 2/3
• Non-inferiority Clinic of Kollagenase® Compared Iruxol® in Treatment of Cutaneous UlcersSuspendedNCT00701974Phase 2/3
• Sodic Heparin Effectiveness of the Treatment of BurnsWithdrawnNCT00701623Phase 2/3
• Safety Evaluation of Use Sodic EnoxaparinCompletedNCT00673426Phase 3

← Azidus Brasil overview and focus areas